THOMAS SCIASCIA

Insider Reports History

Location
Danbury, CT
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by THOMAS SCIASCIA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Chief Scientific Officer Common Stock 221,373 $1,461,062 $6.60 25 Mar 2025 Direct
Trevi Therapeutics, Inc. Chief Scientific Officer Performance Stock Option (right to buy) 92,000 31 May 2025 Direct
Trevi Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 0 25 Mar 2025 Direct

Insider Reports Filed by THOMAS SCIASCIA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVI Trevi Therapeutics, Inc. 31 May 2025 1 $0 4 Chief Scientific Officer 03 Jun 2025, 16:00
TRVI Trevi Therapeutics, Inc. 25 Mar 2025 3 -$13,602 4 Chief Scientific Officer 26 Mar 2025, 16:30
TRVI Trevi Therapeutics, Inc. 10 Mar 2025 1 $0 4 Chief Scientific Officer 12 Mar 2025, 16:00
TRVI Trevi Therapeutics, Inc. 18 Feb 2025 1 $0 4 Chief Scientific Officer 20 Feb 2025, 16:00
TRVI Trevi Therapeutics, Inc. 19 Aug 2024 3 -$25,293 4 Chief Scientific Officer 21 Aug 2024, 16:00
TRVI Trevi Therapeutics, Inc. 14 Aug 2024 9 -$42,176 4 Chief Scientific Officer 16 Aug 2024, 16:47
TRVI Trevi Therapeutics, Inc. 29 May 2024 3 -$6,124 4 Chief Scientific Officer 31 May 2024, 16:07
TRVI Trevi Therapeutics, Inc. 15 Feb 2024 1 $0 4 Chief Scientific Officer 16 Feb 2024, 16:42
TRVI Trevi Therapeutics, Inc. 16 Feb 2023 1 $0 4 Chief Scientific Officer 16 Feb 2023, 16:23
TRVI Trevi Therapeutics, Inc. 19 Sep 2022 1 $0 4 Chief Medical Officer 19 Sep 2022, 16:30
TRVI Trevi Therapeutics, Inc. 29 Jun 2022 1 $0 4 Chief Medical Officer 01 Jul 2022, 16:51
TRVI Trevi Therapeutics, Inc. 11 Feb 2022 1 $0 4/A Chief Medical Officer 01 Jul 2022, 16:44